Latest News about NAUT
Recent news which mentions NAUT
Earnings Scheduled For February 23, 2023
February 23, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
December 13, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 08, 2022
From Benzinga
Earnings Scheduled For November 1, 2022
November 01, 2022
From Benzinga
$7.3 Million Bet On This Penny Stock? Check Out These 4 Penny Stocks Insiders Are Buying
August 23, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 19, 2022
From Benzinga
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
From Benzinga
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
January 06, 2022
From Benzinga
50 Biggest Movers From Yesterday
December 23, 2021
From Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
December 22, 2021
From Benzinga
Cramer Shares His Thoughts On Incyte, Corning And More
December 22, 2021
From Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
From Benzinga
40 Stocks Moving In Monday's Mid-Day Session
December 13, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
November 02, 2021
From Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.